Results 151 to 160 of about 106,528 (297)

Clinical Features and Therapeutic Outcomes in Pyoderma Gangrenosum: A Prospective Cohort Study

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis highly associated with systemic comorbidities. Accurate diagnosis and treatment remain challenging due to its rarity and clinical mimickers. Objectives To evaluate demographic, clinical features and treatment outcomes in patients referred with suspected PG at a tertiary ...
David Croitoru, Nesrine Brahimi, Haleh Zabihi, Cathryn Sibbald, Kyle Seigel, Delaram Shojaei, Eric McMullen, Afsaneh Alavi, Lily Archaempong, Aaron M. Drucker, Adam Weizman, Kenneth Croitoru, Robert Inman, Vincent Piguet   +13 more
wiley   +1 more source

Exploring the Impact of Gender and Age of Onset on Psoriasis Treatment Management. [PDF]

J Clin Med
Lax T, Stemmer E, Fallach N, Shrem G, Schreiber-Divon M, Ayalon S, Giat E, Mor I, Salmon-Divon M.   +8 more
europepmc   +1 more source

Endothelial dysfunction and its treatment in psoriasis patients

, 2017
Yu. M. Shtoda, Natalya A. Slesarenko, А. Л. Бакулев, Sergei R. Utz, А. Н. Платонова   +4 more
openalex   +2 more sources

Bimekizumab for psoriasis treatment: A Canadian real-world multicenter study. [PDF]

JAAD Int
Lovegrove F, Asiniwasis R, Cunningham N, Lipson J, O'Toole A, Purdy K, Sutherland A, Walker K, Gooderham M.   +8 more
europepmc   +1 more source

Trends in Systemic Psoriasis Treatment: Is Psoriasis Still Being Undertreated? [PDF]

Ann Dermatol, 2023
Choi S, Oh S, Yoon HS.
europepmc   +1 more source

Clinical Treatment and Clinical Application Research Progress of Psoriasis and Intestinal Microbiota Dysbiosis

Nana Zhao, Kejia Wang, Yang Jiang, Rongzhong Huang   +3 more
openalex   +2 more sources

Efficacy and safety of HAT1 compared with calcipotriol in the treatment of patients with mild to moderate chronic plaque psoriasis: results from an open‐label randomized comparative pilot clinical study [PDF]

, 2019
Pui-Wai Lee Alex, Sally Williams, Lynda Sutton, T. Yesudas, Chris Sutton, Samisha Thomas, Michael Centola   +6 more
openalex   +1 more source

Absolute and Relative Risk of New-Onset Psoriasis Associated With Tumor Necrosis Factor-α Inhibitor Treatment in Patients With Immune-Mediated Inflammatory Diseases

, 2022
David Thein, Alexander Egeberg, Lone Skov, Nikolai Loft   +3 more
openalex   +2 more sources

Ambient Solar Radiation Predicts Psoriasis Treatment Intensity. [PDF]

Photodermatol Photoimmunol Photomed
Woodie BR, Fleischer AB.
europepmc   +1 more source

Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative

, 2018
G Colombo, Di Matteo S, Chiara Martinotti, SM Jugl, P Gunda, Mariantonietta Naclerio, Bruno GM   +6 more
openalex   +1 more source